Latta and Dingell Introduced BEDROCK Act

The proposed legislation aims to expand domestic biomanufacturing and reduce American reliance on China.

Updated on Sept. 22, 2026 in Manufacturing

Isometric editorial illustration of a large steel bioreactor tank in a clean, sterile laboratory setting.
Representatives Bob Latta and Debbie Dingell introduced the BEDROCK Act on August 27, 2026, to expand domestic biomanufacturing and decrease reliance on foreign supply chains. AI Illustration. Upload story photo >

Live Poll

Should the federal government intervene to shift manufacturing operations back to the United States?

Representatives Bob Latta and Debbie Dingell introduced the BEDROCK Act in the House of Representatives on August 27, 2026. The legislation directs the Secretary of Commerce to create an action plan to bolster the U.S. biomanufacturing industry.

Why it matters

The bill seeks to strengthen domestic supply chains and support American manufacturing jobs by pivoting from foreign dependence. It specifically targets the current industry imbalance where China maintains a dominant share of global fermentation capacity.

The legislation requires the Secretary of Commerce to develop a prioritized action plan for biomanufacturing, a sector currently dominated by Chinese fermentation capacity.

The players

Bob Latta

Bob Latta is a member of the United States House of Representatives who co-sponsored this legislation.

Debbie Dingell

Debbie Dingell is a member of the United States House of Representatives who co-sponsored this legislation.

The details

Biomanufacturing uses biological processes to produce materials and medicines at an industrial scale. The act aims to bridge the gap between American research inventions and large-scale domestic production.

Timeline

  1. Representatives introduced the BEDROCK Act on August 27, 2026.

Market Landscape

The BEDROCK Act follows a pattern set by the CHIPS and Science Act by seeking to onshore critical industrial manufacturing processes. This initiative positions the U.S. to compete more effectively against international rivals for industrial scale market share.

This legislation could eventually influence the availability and cost of domestically produced medicines and biological materials. Customers may see long-term shifts in supply chain reliability for goods produced through industrial fermentation.

The takeaway

The BEDROCK Act represents a legislative effort to align domestic manufacturing capabilities with national security interests in biotechnology. Readers should monitor the bill for potential impacts on the medical and industrial manufacturing sectors.

Further reading

For more information on national production policy, visit Manufacturing.

Live Poll

Should the federal government intervene to shift manufacturing operations back to the United States?